CoChat

Cohort Profile: The Health In Men Study (HIMS)

Norman, P. E, Flicker, L., Almeida, O. P, Hankey, G. J, Hyde, Z., Jamrozik, K. · 2009 · International Journal of Epidemiology
Cited by 215

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The Health In Men Study (HIMS) arose out of a population-based randomized trial of screening for abdominal aortic aneurysms (AAAs) conducted in Perth, Western Australia in 1996–99.1,2 Only men aged 65 years and over were recruited into the trial as AAAs are uncommon below this age and are six times more common in men than women. The aim of the trial was to assess whether screening reduced mortality from AAA. Secondary outcomes included assessments of the impact of screening on all-cause mortality and quality of life3 and a study of the rates of expansion of screen-detected AAAs.4 The numbers of participants at each phase of the study are summarized in Figure 1. All men were identified from an electronic copy of the electoral roll, enrolment to vote being compulsory for all Australian adults. The target age range was 65–79 years and the potentially available number of men in Perth (the capital of Western Australia) was about 50 000. Of these, 8801 men were not randomized as they were resident in a satellite town (circa 35 km away from Perth). Based on a sample size calculation, we selected 41 000 men who were resident in Perth and were expected to be aged 65–79 years at the projected mid-point of screening. Men were randomized into invited and control groups of equal size, in strata defined by 5-year age-group and postcode of residence. After exclusion of 2296 men dying prior to invitation, 19 352 men were invited and 12 203 (63.1%) attended for baseline screening. As initial versions of the electoral roll only contained age in 5-year strata, some men over the age of 79 years were included. As a result of this, 725 (5.9%) of attending men were aged 80–83 years at the time of screening. The age strata, country of birth and deaths are shown in Table 1. Analyses of all-cause mortality have revealed evidence of response bias with the participating men experiencing about half the mortality of men who did not attend following invitation.2 Numbers of men at each phase of recruitment and surveys. Follow-up with identified record linkage (solid grey background) or with de-identified aggregated age-standardized outcomes (stippled background) The age strata, country of birth and deaths of men participating in HIMS surveys aAt 26 March 2007. The age strata, country of birth and deaths of men participating in HIMS surveys aAt 26 March 2007. HIMS was initially the name given to a follow-up survey of surviving men undertaken in 2001–04. However, we now use the acronym for investigations of any men in the original study population. Most research in HIMS involves men who participated in the initial screening for AAA (1996–99) and, in particular the follow-up survey when blood samples were obtained (2001–04). However, some outcomes are assessed in men from the control (non-invited) group from the original trial (Figure 1). Apart from measuring the diameter of the infra-renal aorta by ultrasound scanning, the trial represented an opportunity to collect demographic and risk factor data relating to wide range of common health conditions in older men. Whilst the focus of the initial study was AAA and other forms of cardiovascular disease (CVD), the follow-up survey undertaken in 2001–04 expanded the scope to include cognitive function and psycho-social elements of health and well-being. Outcomes of participants are being monitored via the Western Australian Linked Data System (described below). This system allows HIMS to assess fatal and most major non-fatal episodes for an indefinite period into the future, and to place these in the context of significant health events affecting participants at any time since the beginning of data collection (which ranges from 1966–81 for the various datasets). Each man completed a questionnaire assessing aspects of history and lifestyle relevant to AAA and CVD: smoking status (never, ex-smoker, current smoker and number of cigarettes/cigars or grams of tobacco per day); birthplace; marital status (never married, now married, separated but not divorced, divorced, widowed, de facto); education (never attended school, primary school, some high school, completed high school, completed tertiary degree); alcohol [non-drinker, number of standard drinks (each containing 10 g of alcohol) typically consumed for each day of the week]; addition of salt to food (rarely or never, sometimes, almost always or always); usual type of milk consumed (condensed, full cream, full cream and reduced fat, reduced fat, skim or none, other); frequency of eating meat and fish (each 6 + times/week, 3–5/week, 1–2/week, <1/week, never). A history of, or treatment for Coronary Heart Disease (CHD), hypertension, dyslipidaemia or diabetes, a history of aspirin intake, asthma or bronchitis and family history of CVD. Symptomatic peripheral arterial disease (PAD) was assessed using the Edinburgh Claudication Questionnaire (ECQ).5 Socio-economic status was estimated using the Socio-Economic Indices For Areas (SEIFA), which were der

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ije/dyn041

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 215

Metadata

Authors
Norman, P. E., Flicker, L., Almeida, O. P., Hankey, G. J., Hyde, Z., & Jamrozik, K.
Venue
International Journal of Epidemiology
Published
2008-03-03
Volume
38
Issue
1
Pages
48-52
ISSN
  • 0300-5771 (ISSN-L)
  • 1464-3685
OpenAlex
W2141345515
Cited by
215
References
1
FWCI
17.53
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.